Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Stage II Breast Cancer|Stage III Breast Cancer
Interventions: BIOLOGICAL: Autologous dendritic cell vaccination
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra
Collaborators: Spanish Clinical Research Network - SCReN|National Institutes of Health (NIH)